Business Description
Labcorp Holdings Inc
NAICS : 621511
SIC : 8071
ISIN : US50540R4092
Share Class Description:
LH: Ordinary SharesDescription
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.2 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.95 | |||||
| Debt-to-EBITDA | 5.36 | |||||
| Interest Coverage | 5.87 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.66 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.9 | |||||
| 3-Year EBITDA Growth Rate | -21 | |||||
| 3-Year EPS without NRI Growth Rate | -11.3 | |||||
| 3-Year FCF Growth Rate | -17.7 | |||||
| 3-Year Book Growth Rate | -1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 9.15 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.09 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.41 | |||||
| 9-Day RSI | 71.69 | |||||
| 14-Day RSI | 65.37 | |||||
| 6-1 Month Momentum % | 10.98 | |||||
| 12-1 Month Momentum % | 11.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.44 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 0.44 | |||||
| Days Inventory | 18.61 | |||||
| Days Sales Outstanding | 58 | |||||
| Days Payable | 28.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.26 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| Forward Dividend Yield % | 1.26 | |||||
| 5-Year Yield-on-Cost % | 1.26 | |||||
| 3-Year Average Share Buyback Ratio | 4.9 | |||||
| Shareholder Yield % | 1.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.92 | |||||
| Operating Margin % | 8.94 | |||||
| Net Margin % | 3.43 | |||||
| FCF Margin % | 6.63 | |||||
| ROE % | 5.46 | |||||
| ROA % | 2.55 | |||||
| ROIC % | 5.14 | |||||
| 3-Year ROIIC % | 55.12 | |||||
| ROC (Joel Greenblatt) % | 19.4 | |||||
| ROCE % | 6.05 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 44.32 | |||||
| Forward PE Ratio | 14.28 | |||||
| PE Ratio without NRI | 15.83 | |||||
| Shiller PE Ratio | 17.9 | |||||
| Price-to-Owner-Earnings | 71.89 | |||||
| PS Ratio | 1.52 | |||||
| PB Ratio | 2.34 | |||||
| Price-to-Free-Cash-Flow | 22.94 | |||||
| Price-to-Operating-Cash-Flow | 13.97 | |||||
| EV-to-EBIT | 30.99 | |||||
| EV-to-Forward-EBIT | 14.5 | |||||
| EV-to-EBITDA | 17.68 | |||||
| EV-to-Forward-EBITDA | 11.24 | |||||
| EV-to-Revenue | 2 | |||||
| EV-to-Forward-Revenue | 1.88 | |||||
| EV-to-FCF | 30.22 | |||||
| Price-to-Projected-FCF | 0.96 | |||||
| Price-to-Median-PS-Value | 1.07 | |||||
| Earnings Yield (Greenblatt) % | 3.23 | |||||
| FCF Yield % | 4.42 | |||||
| Forward Rate of Return (Yacktman) % | 0.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:LH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Labcorp Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12,712.8 | ||
| EPS (TTM) ($) | 5.15 | ||
| Beta | 1.02 | ||
| Volatility % | 17.55 | ||
| 14-Day RSI | 65.37 | ||
| 14-Day ATR ($) | 5.220526 | ||
| 20-Day SMA ($) | 219.1515 | ||
| 12-1 Month Momentum % | 11.89 | ||
| 52-Week Range ($) | 191.97 - 239.5 | ||
| Shares Outstanding (Mil) | 83.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Labcorp Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Labcorp Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Labcorp Holdings Inc Frequently Asked Questions
What is Labcorp Holdings Inc(LH)'s stock price today?
The current price of LH is $228.27. The 52 week high of LH is $239.50 and 52 week low is $191.97.
When is next earnings date of Labcorp Holdings Inc(LH)?
The next earnings date of Labcorp Holdings Inc(LH) is 2025-02-14 Est..
Does Labcorp Holdings Inc(LH) pay dividends? If so, how much?
The Dividend Yield %  of Labcorp Holdings Inc(LH) is 1.26% (As of Today), Highest Dividend Payout Ratio of Labcorp Holdings Inc(LH) was 0.21. The lowest was 0.16. And the median was 0.19. The  Forward Dividend Yield % of Labcorp Holdings Inc(LH) is 1.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers